7,544.10

+167.24

+2.27%

52,335.52

+1,049.79

+2.05%

25,205.64

+626.22

+2.55%

2,829.48

+75.37

+2.74%

4.8780

+0.0190

+0.39%

20.29

-5.35

-20.83%

4,112.80

+37.90

+0.93%

74,468.50

-1,185.37

-1.57%

Crude Oil Dec 26

87.60

-3.23

-3.56%

US Private Equity

10,772.76

+11.83

+0.11%

Paris - Delayed Quote EUR

MedinCell S.A. (MEDCL.PA)

30.00 +1.56 (+5.49%)

At close: 5:37:20 PM GMT+1

MedinCell (ENXTPA:MEDCL), Why Is The Story Getting More Complicated?

Simply Wall St. 16h ago

MEDCL.PA
+5.49%
Is MedinCell (ENXTPA:MEDCL) Trading Above Fair Value On Sales?

Simply Wall St. 8d ago

MEDCL.PA
+5.49%
MedinCell (ENXTPA:MEDCL) Extends Debt Runway On Fresh Financing While Valuation Debate Builds

Simply Wall St. 15d ago

MEDCL.PA
+5.49%
MedinCell (ENXTPA:MEDCL) Secures €41.8 Million In Non Dilutive Financing

Simply Wall St. 22d ago

MEDCL.PA
+5.49%
MedinCell (ENXTPA:MEDCL) Stock Could Be Overvalued On FDA Approval News

Simply Wall St. 27d ago

TEVA

MEDCL.PA
+5.49%
FDA approves Teva’s monthly injection of olanzapine for schizophrenia

Pharmaceutical Technology 28d ago

TEVA

MEDCL.PA
+5.49%
MedinCell (ENXTPA:MEDCL) Wins FDA Approval For WELTRUZA, Is The Stock Fully Priced?

Simply Wall St. 30d ago

MEDCL.PA
+5.49%
TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot

Stocktwits 30d ago

MEDCL.PA
+5.49%
TEVA
Is It Too Late To Consider MedinCell (ENXTPA:MEDCL) After Its 1 Year 78% Rally?

Simply Wall St. 5mo ago

MEDCL.PA
+5.49%

Mobilize your Website

View Site in Mobile | Classic

Share by: